Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Campbell Systematic Reviews|March 13, 2023
Safety interventions for the prevention of accidents at work: A systematic reviewJohnny Dyreborg, Hester Johnstone Lipscomb, Kent Nielsen, et al.
Neurobiology of Aging|March 8, 2023
Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's diseaseMichael A Kelberman, Jacki M Rorabaugh, Claire R Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2019
The Opioid Crisis and the Future of Addiction and Pain TherapeuticsNathan P Coussens, G Sitta Sittampalam, Samantha G Jonson, et al.
Frontiers in Allergy|April 7, 2022
Rhino Conjunctivitis and Asthma Among Seafood Processing Workers in Greenland. A Cross-Sectional StudyBirgitte Hamann Laustsen, Øyvind Omland, Else Toft Würtz, et al.
Psychopharmacology|March 25, 2017
Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10aJillian R Hufgard, Michael T Williams, Matthew R Skelton, et al.
BMC Public Health|April 4, 2025
Musculoskeletal disorders and other occupational health outcomes among sanitation workers in Nepal: A community based cross-sectional survey exploring the risk factors, knowledge, and practicesSamip Khatri, Gita Kumari Shah, Pratibha Bhandari, et al.
Biological Psychiatry|February 3, 2016
Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 ReceptorMasaaki Iwata, Kristie T Ota, Xiao-Yuan Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 6, 2005
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapineKurt Rasmussen, Mark J Benvenga, Frank P Bymaster, et al.
Nature Medicine|November 8, 2016
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanismAkihiko S Kato, Kevin D Burris, Kevin M Gardinier, et al.
Pageof 6